Photobiomodulation Therapy for Scar Quality After Facial Wound Closure

This study is a prospective pilot randomized controlled trial designed to evaluate the effect of photobiomodulation therapy (PBMT) on scar quality following traumatic facial wound closure. Traumatic facial wounds often result in aesthetically and functionally significant scars, which may negatively affect patients' quality of life. PBMT has been proposed as a non-invasive adjunctive therapy that may enhance tissue repair, reduce inflammation, and improve scar outcomes. In this study, patients with traumatic facial wounds undergoing primary closure will be randomly assigned to receive either PBMT or sham treatment following suture removal. Scar quality will be assessed using validated clinical scales over a defined follow-up period. The findings of this study aim to provide clinical evidence regarding the effectiveness of PBMT in improving scar appearance and overall healing outcomes.

NCT Number	NCT07523204
Lead Sponsor	Hani M. Al-Kufi
Conditions	Traumatic Facial Wounds
Enrollment	36 participants
Start Date	2024-10-17
Primary Completion	2026-10-07 (estimated)
Study Completion	2026-10-20 (estimated)
Updated on ClinicalTrials.gov	2026-04-15